Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 181 | 3 | 204 | +26 |
| Shares | 61.3M | 99.7K | 72.1M | +10.8M (+17.6%) |
| Value | $2.10B | $3.40M | $3.32B | +$1.23B (+58.6%) |
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (20)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Redmile Group, LLC | 419,568 | $14.3M |
| Eventide Asset Management, LLC | 413,906 | $14.1M |
| Holocene Advisors, LP | 178,470 | $6.10M |
| Ghost Tree Capital, LLC | 98,951 | $3.38M |
| Moran Wealth Management, LLC | 69,510 | $2.37M |
| Qube Research & Technologies Ltd | 54,285 | $1.85M |
| Sphera Funds Management Ltd. | 38,959 | $1.33M |
| Advisory Research Inc | 38,326 | $1.31M |
| Man Group plc | – | $632.0K |
| J. Goldman & Co LP | 17,775 | $607.2K |
| Caption Management, LLC | 9,500 | $324.5K |
| Dynamic Technology Lab Private Ltd | 9,371 | $320.0K |
| Group One Trading, L.P. | 8,005 | $273.5K |
| Walleye Trading LLC | 6,923 | $236.5K |
| Exchange Traded Concepts, LLC | 3,967 | $135.5K |
| Belvedere Trading LLC | 955 | $32.6K |
| Park Place Capital Corp | 22 | $752 |
| Larson Financial Group LLC | 17 | $581 |
| Lindbrook Capital, LLC | 14 | $478 |
| Hexagon Capital Partners LLC | 10 | $342 |
Not filed for Q4 2023 yet (3)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 91,500 | $3.12M |
| Connacht Asset Management LP | 8,204 | $280.2K |
| Steward Financial Group LLC | 12 | $0 |